Form 8-K - Current report:
SEC Accession No. 0001193125-24-250638
Filing Date
2024-11-04
Accepted
2024-11-04 16:17:59
Documents
22
Period of Report
2024-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d907851d8k.htm   iXBRL 8-K 47172
2 EX-10.1 d907851dex101.htm EX-10.1 27840
3 EX-10.2 d907851dex102.htm EX-10.2 25117
4 EX-10.3 d907851dex103.htm EX-10.3 83638
5 EX-10.4 d907851dex104.htm EX-10.4 109906
6 EX-10.5 d907851dex105.htm EX-10.5 47013
7 EX-10.6 d907851dex106.htm EX-10.6 58284
8 EX-99.1 d907851dex991.htm EX-99.1 124953
12 GRAPHIC g907851g1102085150877.jpg GRAPHIC 2659
13 GRAPHIC g907851g1105003011291.jpg GRAPHIC 3496
  Complete submission text file 0001193125-24-250638.txt   782236

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA vrca-20241101.xsd EX-101.SCH 2850
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20241101_lab.xml EX-101.LAB 17994
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20241101_pre.xml EX-101.PRE 11261
24 EXTRACTED XBRL INSTANCE DOCUMENT d907851d8k_htm.xml XML 3613
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 241423814
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)